Digital Papillary Adenocarcinoma
Digital papillary adenocarcinoma (also called aggressive digital papillary adenocarcinoma, ADPA) is a very rare malignant cutaneous adnexal neoplasm that invades locally and carries a high risk of distant spread. It arises from the ductal portion of the sweat glands (eccrine or apocrine) and occurs almost exclusively at acral sites: the fingers, toes, palms and soles.
The World Health Organization (WHO) once divided these lesions into "papillary adenoma" and "papillary adenocarcinoma." Long-term follow-up, however, showed that even lesions that looked benign under the microscope could recur and spread to the lungs. The WHO therefore reclassified all of them as a single malignant entity: digital papillary adenocarcinoma (ADPA).
Key Driver Mutations and Genomic Instability
- TP53 mutation: Loss of the TP53 tumor suppressor is the central genetic change. It disables the G1/S checkpoint, so ductal cells pile up many secondary mutations.
- BRAF V600E mutation and EGFR activation: Some molecular studies have found BRAF V600E mutations and overexpression of the epidermal growth factor receptor (EGFR), which speed up tumor cell proliferation and invasion of the surrounding tissue of the digit.
- Loss of the myoepithelial layer (myoepithelial layer breakdown): Thinning or complete loss of the outer myoepithelial cell layer (shown with p63, SMA and podoplanin) marks the breach of the basement membrane and the shift to malignant invasion.
Disease Course and Silent Metastasis
- High local recurrence: After simple excision or enucleation alone, local recurrence reaches 40–50%, usually within 1–5 years.
- Risk of distant spread (especially to the lungs): ADPA tends to spread early through the bloodstream to the lungs (10–30%) and to regional lymph nodes (10–20%). Lung metastases may appear only after decades of follow-up, so long-term systematic surveillance is needed.
Because these tumors arise at the fingertips and toes, where they are easily mistaken for common benign lumps, Haute-Derma follows a strict ADPA management protocol:
- Incisional or excisional biopsy with prompt IHC: To confirm a papillary ductal epithelial origin and assess basement membrane destruction.
- Complete microscopic margin control: Preference for digit-sparing Mohs micrographic surgery, or digit amputation when the tumor has invaded bone or tendon sheath.
- Lung metastasis screening and sentinel lymph node biopsy (SLNB): High-resolution chest CT and regional lymph node ultrasound before definitive surgery.
Histopathology and Immunohistochemistry (IHC) Criteria
Characteristic Features Under the Microscope
Under the light microscope, ADPA shows a complex solid-cystic architecture with these standard features:
- Intracystic papillary projections: Large cystic spaces containing proteinaceous fluid, lined by epithelial papillae supported by fibrovascular cores.
- Back-to-back glands: Solid areas made of tumor cell sheets forming countless crowded glandular lumens with no supporting stroma between them.
- Cellular atypia and increased mitoses: Enlarged, basophilic nuclei that have lost polarity, with prominent nucleoli. There are atypical mitoses (>5 per 10 HPF) and foci of comedo-like necrosis.
- Loss of the myoepithelial layer and deep invasion: The peripheral myoepithelial rim is completely lost; tumor cords push into the subcutaneous tissue, fascia, tendon sheaths, nerves (PNI+) and vessels (LVI+).
Diagnostic Immunohistochemistry (IHC) Panel
| IHC Marker / Stain | Where It Is Expressed | Diagnostic Significance |
|---|---|---|
| EMA / CEA / CK7 | Tumor cell cytoplasm and papillary duct lumens | Strongly positive (+++): confirms sweat duct epithelial origin |
| p63 / podoplanin / calponin | Outer cell layer at the basement membrane | Completely lost or discontinuous: confirms malignant invasion |
| Ki-67 index | Nuclei of dividing tumor cells | Elevated (>15–40%): reflects proliferation rate and aggressiveness |
| p53 | Nuclei of all tumor cells | Mutant pattern: overexpression (>70%) or null (0%) |
| WT1 / ER / PR | Tumor cell cytoplasm / nuclei | Usually negative (0): helps exclude papillary carcinomas metastatic from elsewhere |
High-Frequency Ultrasound and Dermoscopy Criteria
- High-frequency skin ultrasound (20–50 MHz):
- Shape and margins: A hypoechoic, complex multiseptated cystic mass with irregular borders in the subcutis of the digit tip.
- Internal structure: Intracystic hyperechoic nodules projecting into anechoic cyst spaces.
- Color Doppler: Chaotic internal vascularity with high-resistance arterial flow (RI >0.7).
- Dermoscopy:
- Background: Structureless pale pink or milky-red areas interspersed with opaque white fibrous streaks.
- Vessels: Irregularly distributed polymorphous vessels, including arborizing and coiled vessels and blood lagoons.
Clinical Features
- Typical location: Almost always acral (fingers 80–85%, toes 10–15%), usually on the palmar side of the digit or around the nail folds.
- Appearance: A single firm nodule under the skin, skin-colored or reddish-purple, 1–3 cm in size.
- Symptoms: Usually painless or only mildly tender when bumped, growing quietly over months to years. This harmless-seeming behavior is exactly why patients and doctors often underestimate it.
Multimodal Treatment at Haute-Derma
Managing digital papillary adenocarcinoma at Haute-Derma means balancing complete cancer removal against preserving as much hand or foot function as possible:
Prompt Microscopic Assessment and Systemic Screening
- 50 MHz ultrasound and MRI of the digit: Accurately shows how far the tumor has infiltrated the flexor/extensor tendon sheaths, periosteum and phalanges.
- High-resolution chest CT (mandatory): Performed for every ADPA patient to rule out silent "cannonball" lung metastases.
- Confirmatory biopsy with IHC: A panel of EMA, CK7, CEA, p63, podoplanin and Ki-67 to assess basement membrane destruction.
Definitive Surgery With Complete Margin Control
Digit-Sparing Mohs Micrographic Surgery:
- For early lesions that have not invaded bone or the deep tendon sheath.
- The tumor is removed and 100% of the side and deep margins are checked on frozen sections, aiming for clear margins (R0) without amputation, preserving as much movement as possible.
Digit Amputation:
- Required when the tumor has invaded the phalanx or the flexor/extensor tendon sheath, or after repeated recurrence. Amputation is done at the distal interphalangeal (DIP) or metacarpophalangeal joint to achieve a microscopic margin of more than 1 cm.
Adjuvant Therapy and Long-Term Recurrence Management
- Sentinel lymph node biopsy (SLNB) and radiotherapy: If ultrasound shows suspicious regional nodes, we perform FNA or SLNB. Adjuvant radiotherapy is used for extensive perineural invasion (PNI+) or close margins that cannot be re-excised.
- Rehabilitation and tissue repair: The defect is closed with a local flap or a split-thickness skin graft (STSG), combined with exosome/PDRN therapy to speed healing and support hand therapy to restore finger movement.
- Regular lung surveillance: Chest CT every 6 months for the first 5 years, then every 12 months for the next 5 years, to catch late lung metastases early.
